Sandra Schröder Joins CHEPLAPHARM as VP Scientific

On June 1, 2025, Sandra Schröder became the Vice President Scientific at CHEPLAPHARM, a global pharmaceutical company based in Greifswald. This newly created role endows her with the responsibility for scientific oversight across the organization, including Quality, Regulatory Affairs, Pharmacovigilance, and Medical Affairs. Schröder transitions from F. Hoffmann-La Roche AG in Basel, where she amassed over 25 years of management experience.

Sandra Schröder's primary goal as VP Scientific is to maintain product quality and regulatory compliance in all markets. Her duties extend to integrating new products into CHEPLAPHARM's systems. Reporting directly to Dr. Bianca Juha, Chief Scientific Officer, Schröder brings considerable international expertise to her position.

Dr. Bianca Juha emphasized the importance of the VP Scientific role, expressing confidence in Schröder's capability given her extensive background in quality management and regulatory affairs.